# Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

> **NCT00003135** · PHASE2 · UNKNOWN · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 34 (estimated)

## Conditions studied

- Breast Cancer
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** pegylated liposomal doxorubicin hydrochloride
- **PROCEDURE:** hyperthermia treatment

## Key facts

- **NCT ID:** NCT00003135
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-11
- **Primary completion:** 2009-09
- **Final completion:** —
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2009-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003135, "Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*